Evidence map›Paper›PMID 36124395›Full record

ArticleInterventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2024

Endovascular treatment for M3 occlusions.

Gokhan Ozdemir, Alper Eren, Recep Aygul, Fettah Eren, Nazım Kizildag, Idris Kocaturk, Azer Mammadi, Ayse Nur Ersoy, Muslu Kazım Korez

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Endovascular treatment for anterior cerebral artery occlusions.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2024
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Gokhan OzdemirDepartment of Neurology, Center of Stroke, Selcuk University Medical Faculty, Konya, Turkey.ORCID 0000-0001-8140-6333
Alper ErenDepartment of Neurology, Center of Stroke, Ataturk University Medical Faculty, Erzurum, Turkey.
Recep AygulDepartment of Neurology, Center of Stroke, Selcuk University Medical Faculty, Konya, Turkey.
Fettah ErenDepartment of Neurology, Center of Stroke, Selcuk University Medical Faculty, Konya, Turkey.
Nazım KizildagErzurum Education and Research Hospital, Erzurum, Turkey.
Idris KocaturkDepartment of Neurology, Binali University Medical Faculty, Erzincan, Turkey.
Azer MammadiDepartment of Neurology, Center of Stroke, Selcuk University Medical Faculty, Konya, Turkey.
Ayse Nur ErsoyDepartment of Neurology, Center of Stroke, Selcuk University Medical Faculty, Konya, Turkey.
Muslu Kazım KorezDepartment of Biostatistics, Selcuk University Medical Faculty, Konya, Turkey.
Selçuk University · TRAtatürk University · TRErzincan Binali Yıldırım University · TRErzurum Regional Training and Research Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEndovascular treatment (ET) is a beneficial treatment for M1-2 occlusions of the middle cerebral artery. Mortality and disability rates are high if large vessel occlusions are not treated. While these rates are lower in M3 occlusions, important branch blockages can lead to disability. Endovascular treatment of small vessel occlusions is difficult, and there are no studies on the effectiveness of endovascular treatment for M3 occlusions. Accordingly, in this study, our aim was to assess the feasibility, safety, and preliminary efficacy of endovascular therapy for M3 occlusions.

methodsThis study involved a retrospective analysis of a prospectively collected from two centres for acute ischemic stroke of the anterior system between July 2015 and April 2020. Demographic, radiologic, procedural and outcome variables were collected for patients who underwent endovascular therapy for acute ischemic stroke of the anterior system.

resultsComplete or near complete reperfusion (mTICI 2b-3) of the M3 occlusion was achieved in 15 cases (38.5%). Complete (mTICI 3) reperfusion was achieved in 24 cases (61.5%). Twenty-six patients were treated for primary M3 occlusion, while 13 patients with M3 occlusion were treated as a rescue strategy after successful treatment of a proximal greater vascular occlusion. Complete or near complete reperfusion (mTICI 2b-3) of primary occlusion was achieved in eight cases (30.8%), and complete (mTICI 3) reperfusion was achieved in 18 cases (69.2%). In addition, complete or near complete reperfusion (mTICI 2b-3) of rescue M3 occlusion was achieved in seven cases (%53.8), while complete (mTICI 3) reperfusion was achieved in six cases (46.2%). Only one patient with primary M3 occlusion had ICH due to extravasation. The patient's neurological examination one month later was normal.

conclusionsThis retrospective study demonstrates that endovascular treatment of M3 occlusions is safe, effective and reliable.

Indexed as

Endovascular ProceduresIschemic StrokeAgedAged, 80 and overCerebral AngiographyFemaleHumansInfarction, Middle Cerebral ArteryMaleMiddle AgedRetrospective StudiesTreatment Outcomeacute ischemic strokeendovascular treatmentM3 occulusionmiddle serebral artery

Identifiers

PMID36124395
PMCPMC11095351
OpenAlexW4296416627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.